NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

From the 10-Q is sounds like IDH mutations are the last thing that must be resolved before the trial can be locked, all the other information is essentially locked. In the manuscript that preceded that statement it was pretty clear that some of the clinicians involved, or their families, were hit with Covid-19, and that clearly delayed collecting the clinical data. Now the IDH information is being gathered by others and it seems like just a matter of time before it's all in, and data lock is called.

From the discussion, September sounds pretty certain for TLD, but I suspect it will be late September, not just after Labor Day.

I would hope that when they issue TLD they will try to summarize in layman's language, as well as discussing certain FDA goals. I believe in layman's language the benefit of the vaccine is clear, the same may not be true if technically we failed to meet some FDA magic number.

Gary